Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021GlobeNewsWire • 11/15/21
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment OptionGlobeNewsWire • 11/12/21
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/10/21
Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/10/21
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common StockGlobeNewsWire • 11/10/21
Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common StockGlobeNewsWire • 11/09/21
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial SiteGlobeNewsWire • 11/08/21
Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in AustraliaGlobeNewsWire • 11/04/21
Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/03/21
Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021GlobeNewsWire • 11/01/21
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth ConferenceGlobeNewsWire • 10/12/21
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of DirectorsGlobeNewsWire • 09/14/21
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock ExchangeGlobeNewsWire • 08/25/21
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a StrokeGlobeNewsWire • 08/17/21
Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/13/21
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and PhysiciansGlobeNewsWire • 08/11/21
Will Helius Medical Technologies, Inc. (HSDT) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 08/05/21
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in JulyGlobeNewsWire • 07/12/21
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical OfficerGlobeNewsWire • 07/08/21
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and TherapeuticsGlobeNewsWire • 07/07/21